GC Therapeutics (Series A)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $146,758,644
Company Info
- Founders
- Parastoo Kohshakhlagh
- Company Description
- A biotech company using synthetic biology to program stem cells into any cell type, purportedly with best-in-class efficiency, speed, and scalability; they dictate cells fates in a single step and have validated cells for many applications. GC Therapeutics uses synthetic biology to efficiently, quickly, and scalablely program patient-derived stem cells into any cell type.
- Market
- Healthcare & Wellness
- Coinvestors
- Mubadala Capital,Cormorant,AH Bio Fund